Skip to search formSkip to main contentSkip to account menu

Recombivax

Known as: Recombivax HB, Recombivax HBR, Recombivax-HB 
National Institutes of Health

Related topics

Related topics

6 relations
0.5 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Prefilled Syringe [Recombivax]1 ML Hepatitis B Surface Antigen Vaccine 0.04 MG/ML Injection [Recombivax]

Broader (3)

Hepatitis B Surface Antigen VaccineHepatitis B VaccinesVaccines, Synthetic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.
2005
2005
Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
2002
2002
In vitro versus in vivo concordance: a case study of the replacement of an animal potency test with an immunochemical assay.
Early in its development, the potency of Merck's recombinant hepatitis B vaccine, RECOMBIVAX HB, was monitored using an assay… 
2000
2000
Update: expanded availability of thimerosal preservative-free hepatitis B vaccine.
  • MMWR. Morbidity and mortality weekly report
  • 2000
  • Corpus ID: 12047512
Thimerosal, a mercury-based compound, is no longer used as a preservative in any of the pediatric hepatitis B vaccines licensed… 
1999
1999
Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRP…
1997
1997
Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants
OBJECTIVE To assess the safety, tolerability and immunogenicity of COMVAX, a liquid, bivalent Haemophilus influenzae type b… 
1997
1997
Hepatitis B vaccine booster dose: low-dose recombinant hepatitis B vaccines as a booster dose.
Review
1997
Review
1997
Vaccines for hepatitis A and B. The latest recommendations on safe and extended protection.
Hepatitis A vaccines (Havrix and Vaqta), administered in two doses, provide long-term protection. Target groups include… 
1995
1995
Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults.
1991
1991
Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)